[vc_row][vc_column][vc_column_text css_animation=”fadeInDown”]

MannKind Corporation (MNKD) Stock Rating Reaffirmed by HC Wainwright

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][vc_column_text css_animation=”fadeInLeft”]HC Wainwright reiterated their buy rating on shares of MannKind Corporation (NASDAQ:MNKD) in a research report report published on Wednesday, November 8th.

Other analysts also recently issued reports about the stock. Zacks Investment Research upgraded shares of MannKind Corporation from a sell rating to a hold rating in a report on Wednesday, October 11th. ValuEngine downgraded shares of MannKind Corporation from a hold rating to a sell rating in a report on Wednesday, October 18th. Finally, Maxim Group reiterated a hold rating on shares of MannKind Corporation in a report on Wednesday, November 1st. Three research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $0.92.

Shares of MannKind Corporation (NASDAQ:MNKD) traded up $0.06 during midday trading on Wednesday, hitting $3.26. 2,442,800 shares of the stock traded hands, compared to its average volume of 4,101,063. The company has a debt-to-equity ratio of -0.43, a quick ratio of 0.28 and a current ratio of 0.31. MannKind Corporation has a one year low of $0.67 and a one year high of $6.96.[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_raw_html]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[/vc_raw_html][vc_raw_html]JTNDY2VudGVyJTNFJTBBJTNDc2NyaXB0JTIwYXN5bmMlMjBzcmMlM0QlMjIlMkYlMkZwYWdlYWQyLmdvb2dsZXN5bmRpY2F0aW9uLmNvbSUyRnBhZ2VhZCUyRmpzJTJGYWRzYnlnb29nbGUuanMlMjIlM0UlM0MlMkZzY3JpcHQlM0UlMEElM0MlMjEtLSUyMFNjYWxwJTIwcmVkJTIwYXV0byUyMC0tJTNFJTBBJTNDaW5zJTIwY2xhc3MlM0QlMjJhZHNieWdvb2dsZSUyMiUyMCUyMCUyMCUyMHN0eWxlJTNEJTIyZGlzcGxheSUzQWJsb2NrJTIyJTBBJTIwJTIwJTIwJTIwJTIwZGF0YS1hZC1jbGllbnQlM0QlMjJjYS1wdWItMjkwNTE4MjMzOTAwMjg5MCUyMiUwQSUyMCUyMCUyMCUyMCUyMGRhdGEtYWQtc2xvdCUzRCUyMjk1NDA1MjcyMzElMjIlMEElMjAlMjAlMjAlMjAlMjBkYXRhLWFkLWZvcm1hdCUzRCUyMmF1dG8lMjIlM0UlM0MlMkZpbnMlM0UlMEElM0NzY3JpcHQlM0UlMEElMjhhZHNieWdvb2dsZSUyMCUzRCUyMHdpbmRvdy5hZHNieWdvb2dsZSUyMCU3QyU3QyUyMCU1QiU1RCUyOS5wdXNoJTI4JTdCJTdEJTI5JTNCJTBBJTNDJTJGc2NyaXB0JTNFJTBBJTNDJTJGY2VudGVyJTNF[/vc_raw_html][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css_animation=”fadeIn”]MannKind Corporation (NASDAQ:MNKD) last announced its quarterly earnings results on Tuesday, November 7th. The biopharmaceutical company reported ($0.31) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.11). The firm had revenue of $2.04 million during the quarter, compared to analyst estimates of $2.56 million. MannKind Corporation had a negative net margin of 155.83% and a negative return on equity of 24.93%. The business’s revenue was down 98.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.30 earnings per share. analysts expect that MannKind Corporation will post -1.13 EPS for the current year.

In other news, Director Kent Kresa bought 166,600 shares of the firm’s stock in a transaction that occurred on Friday, October 13th. The stock was acquired at an average cost of $6.00 per share, with a total value of $999,600.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is currently owned by company insiders.

A number of hedge funds have recently added to or reduced their stakes in the business. Harel Insurance Investments & Financial Services Ltd. boosted its position in MannKind Corporation by 20.1% during the second quarter. Harel Insurance Investments & Financial Services Ltd. now owns 588,520 shares of the biopharmaceutical company’s stock worth $830,000 after purchasing an additional 98,520 shares during the period. Balyasny Asset Management LLC bought a new position in MannKind Corporation during the second quarter worth $568,000. LMR Partners LLP acquired a new stake in shares of MannKind Corporation during the second quarter worth $352,000. KCG Holdings Inc. lifted its holdings in shares of MannKind Corporation by 268.0% during the first quarter. KCG Holdings Inc. now owns 147,952 shares of the biopharmaceutical company’s stock worth $219,000 after buying an additional 107,752 shares in the last quarter. Finally, Dimensional Fund Advisors LP acquired a new stake in shares of MannKind Corporation during the third quarter worth $270,000. 13.99% of the stock is owned by hedge funds and other institutional investors.[/vc_column_text][vc_raw_html]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[/vc_raw_html][/vc_column][/vc_row]